Table 1 Characteristics of the study population.
From: Fecal calprotectin in healthy children aged 4–16 years
Age range (years) | n | Age median (1st, 3rd quartiles) (years) | Gender male/female n (%) |
|---|---|---|---|
4–16 | 212 | 9.2 (6.2, 11.5) | 108 (50.9)/104 (49.1%) |
4 to < 9 | 100 | 6.2 (5.2, 7.6) | 50 (50%)/50 (50%) |
9–16 | 112 | 11.5 (10.3, 12.4) | 58 (51.8%)/54 (48.2%) |
